Completed
The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma
NCT00001114
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
- Locations
-
- Stanford CRS Palo Alto, California, United States
- University of Colorado Hospital CRS Aurora, Colorado, United States
- Northwestern University CRS Chicago, Illinois, United States
- Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States